日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The progress of hyaluronic acid's application in therapeutic delivery

透明质酸在治疗递送中的应用进展

期刊:Therapeutic Delivery
影响因子:2.2
doi:10.1080/20415990.2025.2483150
Laffleur, Flavia; Bachleitner, Katharina; Millotti, Gioconda; Lagast, Jennifer; Veider, Florina; Bernkop-Schnürch, Andreas
发表日期：2025
文献求助 收藏

A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2

一名60岁男性在接种SARS-CoV-2 mRNA疫苗48小时后出现心肌炎病例

期刊:Clinical Research in Cardiology
影响因子:3.7
doi:10.1007/s00392-021-01946-4
Habedank, Dirk; Lagast, Antonia; Novoa-Usme, Monica; Atmowihardjo, Iskandar
心肌炎
心血管
SARS-CoV-2
发表日期：2022
文献求助 收藏

The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers

表皮松解症患者及其照护者面临的挑战：如何应对和管理该疾病

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-019-1279-y
Bruckner, Anna L; Losow, Michael; Wisk, Jayson; Patel, Nita; Reha, Allen; Lagast, Hjalmar; Gault, Jamie; Gershkowitz, Jayne; Kopelan, Brett; Hund, Michael; Murrell, Dedee F
发表日期：2020
文献求助 收藏

Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)

研究性外用乳膏 SD-101（6% 尿囊素）治疗大疱性表皮松解症患者的疗效和耐受性：一项 3 期随机、双盲、赋形剂对照试验（ESSENCE 研究）

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-020-01419-3
Paller, Amy S; Browning, John; Nikolic, Milos; Bodemer, Christine; Murrell, Dedee F; Lenon, Willistine; Krusinska, Eva; Reha, Allen; Lagast, Hjalmar; Barth, Jay A
发表日期：2020
文献求助 收藏

Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study

大疱性表皮松解症的伤口愈合：来自 ESSENCE 3 期研究赋形剂组的数据

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-020-01435-3
Murrell, Dedee F; Paller, Amy S; Bodemer, Christine; Browning, John; Nikolic, Milos; Barth, Jay A; Lagast, Hjalmar; Krusinska, Eva; Reha, Allen
发表日期：2020
文献求助 收藏

Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study

米格司他在日本人群中的疗效和安全性：ATTRACT 研究的亚组分析

期刊:Clinical and Experimental Nephrology
影响因子:1.7
doi:10.1007/s10157-019-01810-w
Narita, Ichiei; Ohashi, Toya; Sakai, Norio; Hamazaki, Takashi; Skuban, Nina; Castelli, Jeffrey P; Lagast, Hjalmar; Barth, Jay A
发表日期：2020
文献求助 收藏

Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study

甲状旁腺激素 rhPTH(1-84) 对甲状旁腺功能减退症患者磷酸盐稳态和维生素 D 代谢的影响：REPLACE 3 期研究

期刊:Endocrine
影响因子:2.9
doi:10.1007/s12020-016-1141-0
Clarke, Bart L; Vokes, Tamara J; Bilezikian, John P; Shoback, Dolores M; Lagast, Hjalmar; Mannstadt, Michael
代谢
PTH
免疫/内分泌
发表日期：2017
文献求助 收藏

Antihypertensive Utility of Perindopril in a Large, General Practice‐Based Clinical Trial

培哚普利在大型全科医疗临床试验中的抗高血压疗效

期刊:Journal of Clinical Hypertension
影响因子:2.5
doi:10.1111/j.1524-6175.2001.00826.x
Bakris, G; Gradman, A; Reif, M; Wofford, M; Munger, M; Harris, S; Vendetti, J; Michelson, E L; Wang, R; Frishman, William H; Yancy, Clyde W; Julius, Stevo; Cohn, Jay N; Neutel, Joel; Weber, Michael; Turlapaty, Prasad; Shen, Yannan; Dong, Victor; Batchelor, Alicia; Lagast, Hjalmar
心血管
高血压
发表日期：2005
文献求助 收藏

Antihypertensive utility of perindopril in a large, general practice-based clinical trial

培哚普利在大型全科医疗临床试验中的抗高血压疗效

期刊:Journal of Clinical Hypertension
影响因子:2.5
doi:10.1111/j.1524-6175.2004.02440.x
Julius, Stevo; Cohn, Jay N; Neutel, Joel; Weber, Michael; Turlapaty, Prasad; Shen, Yannan; Dong, Victor; Batchelor, Alicia; Lagast, Hjalmar
心血管
高血压
发表日期：2004
文献求助 收藏

Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils

佛波醇肉豆蔻酸酯刺激中性粒细胞质膜上ATP依赖性钙转运

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI111284
Lagast, H; Pozzan, T; Waldvogel, F A; Lew, P D
细胞生物学
中性粒细胞
粒细胞
发表日期：1984
文献求助 收藏